Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Open-label Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Auriхim Multiple Doses in Patients With Recurrent/Refractory В-cell, CD20-positive Non-Hodgkin Lymphoma of Low Tumor Grade or With Follicular Lymphoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03057418
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:33.671570+00:00
Published At
2017-05-23T00:00:00+00:00
Record Updated At
2017-05-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Lymphoma, Non-Hodgkin", "Lymphoma, Follicular"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-05-23"
protocolSection.identificationModule.nctId
"NCT03057418"
protocolSection.identificationModule.officialTitle
"Open-label Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Auri\u0445im Multiple Doses in Patients With Recurrent/Refractory \u0412-cell, CD20-positive Non-Hodgkin Lymphoma of Low Tumor Grade or With Follicular Lymphoma"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Lymphoma, Non-Hodgkin (protocolSection.conditionsModule.conditions)
  • Lymphoma, Follicular (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.